The news is directly about 89bio and its rating by Cantor Fitzgerald. The lowering of the price target might indicate a slightly less optimistic outlook, but the maintained Overweight rating suggests that the analyst still sees the stock as a good investment. This could have a neutral impact on the stock's price in the short term.